Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes.
about
Update on the treatment of type 2 diabetes mellitusGlycemic Control in a Real-Life Setting in Patients with Type 2 Diabetes Treated with IDegLira at a Single Swiss Center.Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone.Insulin degludec/liraglutide (IDegLira) for the treatment of type 2 diabetesThe Clinical Use of a Fixed-Dose Combination of Insulin Degludec and Liraglutide (Xultophy 100/3.6) for the Treatment of Type 2 Diabetes.Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used.Pharmacokinetic evaluation of fixed-ratio combination of insulin degludec and liraglutide in the treatment of type 2 diabetes.Insulin degludec + liraglutide: a complementary combination.Basal Insulin Use With GLP-1 Receptor Agonists.Fixed-ratio combination therapy with GLP-1 receptor agonist liraglutide and insulin degludec in people with type 2 diabetes.Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatideInsulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial.Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?Insulin Degludec/Liraglutide.
P2860
Q28073342-8D3768FD-886A-4C3A-AAA7-3D90EA368B99Q36285880-05E67EC6-4348-468E-8B9A-6CF12C199953Q36712701-E84A3960-C4BF-41F4-8828-D333B4FDF83FQ36971833-8AA8B444-6A63-4E0D-A13D-35419DA7047BQ38629197-A8E89693-330B-485D-9EAF-2F8878F73DE5Q38833204-7C142798-CBEC-4672-92F7-E60582AAEFD1Q38911124-2BBF0BF2-E9D0-44BE-AE78-BF8172867BBDQ38916256-D9D34C0B-D5DF-458C-BAA5-2288D5E75F83Q38940711-85FE0588-E91E-4A9A-B6D4-94A6B078B894Q39204459-1E9AF7B1-3F84-4E78-969B-97DF261D1980Q45402509-C6EDA6B7-C300-42E3-A231-6CBB85791664Q48231903-779523B2-DF21-4BAA-904C-D1F78B05B2BEQ52595142-17156C0F-776A-4D44-B02E-13A619AB9769Q55399743-4601BF68-EB09-4C41-BD59-89A4AF28DD1D
P2860
Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 September 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Benefits of combination of ins ...... d duration of type 2 diabetes.
@en
Benefits of combination of ins ...... d duration of type 2 diabetes.
@nl
type
label
Benefits of combination of ins ...... d duration of type 2 diabetes.
@en
Benefits of combination of ins ...... d duration of type 2 diabetes.
@nl
prefLabel
Benefits of combination of ins ...... d duration of type 2 diabetes.
@en
Benefits of combination of ins ...... d duration of type 2 diabetes.
@nl
P2093
P2860
P356
P1476
Benefits of combination of ins ...... d duration of type 2 diabetes.
@en
P2093
P2860
P356
10.1111/DOM.12574
P50
P577
2015-09-07T00:00:00Z